News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Olympus Biomaterial Corp. To Take Over Sumitomo Pharmaceuticals Co. Ltd.'s Bone Replacement Material Business


10/19/2005 5:10:20 PM

Tokyo (JCNN) - On May 11, Olympus Biomaterial, Sumitomo Osaka Cement (TSE: 5232) and Sumitomo Pharmaceuticals jointly announced that they have reached a basic agreement on a forthcoming transfer of bone replacement material business currently co-conducted by Sumitomo Osaka Cement and Sumitomo Pharmaceuticals. Olympus Biomaterial is scheduled to take over Sumitomo's bone replacement material business by the end of June.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES